GEN-PROBE (NASDAQ:GPRO)
43.19
+0.35 (0.82%)
| GEN-PROBE (NASDAQ:GPRO) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $42.84 | 52 Week High | $49.29 | ||
| Open | $43.05 | 52 Week Low | $35.70 | ||
| Day High | $43.50 | P/E | 25.56 | ||
| Day Low | $42.67 | EPS | $1.69 | ||
| Volume | 246,159 | ||||
| More GPRO Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| PKI | 4 | NANO | 3 |
| LVS | 3 | ESLR | 3 |
| NVTL | 3 | ANDS | 3 |
| RADS | 2 | GERN | 2 |
| ARIA | 2 | GNW | 2 |
| VPRT | 2 | BEZ | 2 |
Entities who have mentioned GPRO
- William Blair | View Related Stories »
- Banc of America | View Related Stories »
- Robert W Baird | View Related Stories »
- JPMorgan | View Related Stories »
- Morgan Stanley | View Related Stories »
- Needham & Company | View Related Stories »
- Jefferies & Co | View Related Stories »
- Deutsche Bank | View Related Stories »
- Morningstar, Inc. | View Related Stories »
- Trading Radar | View Related Stories »
- 13G | View Related Stories »
- Dividend | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- ThinkEquity | View Related Stories »
- Thomas Weisel Partners Group | View Related Stories »
- RBC Capital | View Related Stories »
- Rodman & Renshaw | View Related Stories »
- Jim Cramer | View Related Stories »
- New Enterprise Associates | View Related Stories »
- Citi | View Related Stories »
- Wachovia | View Related Stories »
- UBS | View Related Stories »
- Matrix USA | View Related Stories »
- Natixis Bleichroeder | View Related Stories »
- Cowen & Co | View Related Stories »
View All Major News StreetInsider.com Major News for GPRO
- Gen-Probe (GPRO) Tops Q3 EPS by 6c; Narrows Guidance
- Gen-Probe (GPRO) Reports Mixed Q2 Results; Guides
- Gen-Probe (GPRO) Tops Q1 Earnings Views; Guides FY09
View All ReportsStreetInsider.com Reports on GPRO
- Jefferies & Co Initiates Coverage on Biotechnology and Drugs/Medical Supply Stocks
- Gen-Probe (GPRO) Gets U.S. FDA Clearance for Marketing Prodesse's ProParaflu+ Assay
- Natixis Bleichroeder Initiates Coverage on Gen-Probe (GPRO) with a Buy
- Gen-Probe (GPRO) Tops Q3 EPS by 6c; Narrows Guidance
- Gen-Probe (GPRO) Gets Emergency Use Authorizaton From U.S. FDA for Prodesse ProFlu-ST Test
View All Press ReleasesCompany Press Releases on GPRO
- Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2009 Earnings Conference Call
- DiagnoCure announces fourth quarter 2009 and year-end results
- Gen-Probe to Webcast Presentation at the 28th Annual J.P. Morgan Healthcare Conference
- DiagnoCure to host Q4 2009 and full year earnings conference call and webcast
StreetInsider Reports on GPRO by Category
View All BlogsBlogs on GPRO
- Insider Buying Drops to Lowest Levels in a Year
- Neogen Beats by a Penny
- Forbes' 200 Best Small Companies Through the Magic Formula Screen
- FDA Approves Gen-Probe Assay
- EXACT Sciences: 8 Points Following Q2 Earnings
View All FilingsSEC Filings on GPRO
- Form SC 13G GEN PROBE INC Filed by: BlackRock Inc.
- Form 4 GEN PROBE INC For: Jan 15 Filed by: NORDHOFF HENRY L
- Form 4 GEN PROBE INC For: Jan 13 Filed by: NORDHOFF HENRY L
- Form 4 GEN PROBE INC For: Jan 04 Filed by: KACIAN DANIEL L
- Form 4 GEN PROBE INC For: Jan 04 Filed by: Shapiro Lucy
Comments on GPRO
No comments are currently available.
